BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26916669)

  • 1. Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression.
    Guo YH; Wang Y; Xin M
    Pharm Biol; 2016 Feb; ():1-6. PubMed ID: 26916669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low concentration of formononetin promotes proliferation of estrogen receptor-positive cells through an ERĪ±-miR-375-PTEN-ERK1/2-bcl-2 pathway.
    Guo YH; Tang FY; Wang Y; Huang WJ; Tian J; Lu HL; Xin M; Chen J
    Oncotarget; 2017 Nov; 8(59):100045-100055. PubMed ID: 29245959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo.
    Hu W; Xiao Z
    Cell Physiol Biochem; 2015; 37(3):933-9. PubMed ID: 26381132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line.
    Pan LL; Wang AY; Huang YQ; Luo Y; Ling M
    Asian Pac J Cancer Prev; 2014; 15(17):7065-8. PubMed ID: 25227792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of ERK and Akt pathways.
    Liu Y; He J; Chen X; Li J; Shen M; Yu W; Yang Y; Xiao Z
    Cell Physiol Biochem; 2014; 34(3):637-45. PubMed ID: 25170541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.
    Xin M; Wang Y; Ren Q; Guo Y
    Biomed Pharmacother; 2019 Jan; 109():2084-2089. PubMed ID: 30551465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical findings of nasopharyngeal carcinoma patients and anti-tumor benefits of formononetin.
    Ying K; Liu Y; Zhang C; Shangguan M
    Eur J Pharmacol; 2019 Oct; 861():172619. PubMed ID: 31430458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulating of RASD1 and apoptosis of DU-145 human prostate cancer cells induced by formononetin in vitro.
    Liu XJ; Li YQ; Chen QY; Xiao SJ; Zeng SE
    Asian Pac J Cancer Prev; 2014; 15(6):2835-9. PubMed ID: 24761910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin promotes proliferation and inhibits apoptosis of prostate cancer cells by regulating ERK1/2 signaling pathway.
    Xu CJ; Dong LL; Kang XL; Li ZM; Zhang HY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8341-8348. PubMed ID: 32894540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
    Ye Y; Hou R; Chen J; Mo L; Zhang J; Huang Y; Mo Z
    Horm Metab Res; 2012 Apr; 44(4):263-7. PubMed ID: 22328166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway.
    Huang WJ; Bi LY; Li ZZ; Zhang X; Ye Y
    Pharm Biol; 2013 Dec; ():. PubMed ID: 24359236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pacilitaxel induces human nasopharyngeal carcinoma cell line CNE2 apoptosis and growth inhibition by suppressing PI3K/AKT/p53 signaling pathway].
    Li T
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(24):2147-50. PubMed ID: 27093815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells.
    Chen J; Zhang X; Wang Y; Ye Y; Huang Z
    Mol Carcinog; 2016 Mar; 55(3):312-9. PubMed ID: 25663261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lucialdehyde B suppresses proliferation and induces mitochondria-dependent apoptosis in nasopharyngeal carcinoma CNE2 cells.
    Liu L; Yu Z; Chen J; Liu B; Wu C; Li Y; Xu J; Li P
    Pharm Biol; 2023 Dec; 61(1):918-926. PubMed ID: 37323017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of apoptosis of nasopharyngeal carcinoma cells induced by polysaccharides extracts from Hedyotic diffusa].
    Jing Yan ; Kang Min ; Liu Jin ; Li Jingyu ; Tang Anzhou
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):641-4. PubMed ID: 26201193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway.
    Liang K; Ye Y; Wang Y; Zhang J; Li C
    J Neurol Sci; 2014 Sep; 344(1-2):100-4. PubMed ID: 24996490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Methoxyestradiol induces cell cycle arrest and apoptosis of nasopharyngeal carcinoma cells.
    Zhou NN; Zhu XF; Zhou JM; Li MZ; Zhang XS; Huang P; Jiang WQ
    Acta Pharmacol Sin; 2004 Nov; 25(11):1515-20. PubMed ID: 15525476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
    Xie M; Yi X; Wang R; Wang L; He G; Zhu M; Qi C; Liu Y; Ye Y; Tan S; Tang A
    Cell Physiol Biochem; 2014; 33(5):1475-83. PubMed ID: 24854624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.